Department of Health

Key messages

  • Information and resources to support medical professionals that prescribe medicinal cannabis.

Medicinal cannabis prescribing data

Most medicinal cannabis products available in Australia are unapproved medicines, requiring approval from the Commonwealth Therapeutic Goods Administration (TGA) before a they can be prescribed. The TGA publishes de-identified data on the number of unapproved medicinal cannabis products accessed through their Special Access Scheme (SAS) via their Medicinal Cannabis Access Data DashboardExternal Link , a web-based platform that allows the public to access and filter this data through interactive graphs.

TGA clinical guidance for health professionals and consumers

The Therapeutic Goods Administration (TGA) has developed a series of clinical guidance documents to assist doctors and patients to understand the evidence for the potential uses of medicinal cannabis.

Identifying products

To assist health care professionals in identifying and prescribing unapproved medicinal cannabis products not entered on the ARTG, the Therapeutic Goods Administration (TGA) has published a list of available productsExternal Link by category of active ingredient, along with sponsor details.

The Office of Drug Control (ODC) also publishes an updated list of importers and manufacturers of medicinal cannabis productsExternal Link on its website.

It is important to note that unapproved products can currently only be prescribed via the Authorised Prescriber or Special Access Scheme. Please visit the Health Professionals page on this website for more information on choosing products and prescribing medicinal cannabis.

Reviewed 13 February 2024


Was this page helpful?